The U.S. Food and Drug Administration announced Wednesday the approval of a treatment for pancreatic cancer that could usher in a new era in managing one of the deadliest forms of the disease.

How each outlet headlined it

• Medical Xpress

  The U.S. Food and Drug Administration announced Wednesday the approval of a treatment for pancreatic cancer that could usher in a new era in managing one of the deadliest forms of the disease.
• NPR left

  U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases. n.pr/4d6XUtt
• NYT Business left

  Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more.
• The Hill center

  U.S. Trade Representative Jamieson Greer on Wednesday said that the Trump administration would not “just sit down and take” further retaliation from Canada after Ottawa introduced a dollar-for-dollar match on tariffs. “If there’s further retaliation from the Canadian side, we, of course, we’re not going to just sit down and take that. Our view is…
• STAT News

  A heart drug failure, RevMed's pancreatic cancer drug approved, and more biotech news from The Readout
• The Wall Street Journal right

  Revolution Medicines attracted takeover interest but decided to go it alone. This week’s FDA approval of its pancreatic cancer pill is the payoff. on.wsj.com/4y6GpBx